These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27810451)

  • 1. Surgical Outcome for Moyamoya Disease: Clinical and Perfusion Computed Tomography Correlation.
    Cheung AH; Lam AK; Ho WW; Tsang CP; Tsang AC; Lee R; Lui WM; Leung GK
    World Neurosurg; 2017 Feb; 98():81-88. PubMed ID: 27810451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
    Chen C; Wang H; Hou B; Luo L; Guo Y
    World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease.
    Czabanka M; Peña-Tapia P; Scharf J; Schubert GA; Münch E; Horn P; Schmiedek P; Vajkoczy P
    Cerebrovasc Dis; 2011; 32(4):361-9. PubMed ID: 21921600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Revascularization in North American Adults with Moyamoya Phenomenon: Long-Term Angiographic Follow-up.
    Arias EJ; Dunn GP; Washington CW; Derdeyn CP; Chicoine MR; Grubb RL; Moran CJ; Cross DT; Dacey RG; Zipfel GJ
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1597-608. PubMed ID: 25972283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy.
    Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L
    Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).
    Chen Y; Xu W; Guo X; Shi Z; Sun Z; Gao L; Jin F; Wang J; Chen W; Yang Y
    Eur Radiol; 2016 Jan; 26(1):254-61. PubMed ID: 25925360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified encephalo-duro-periosteal-synangiosis (EDPS) for the revascularization of anterior cerebral artery territory in moyamoya disease: A single-center experience.
    Zhao Y; Yu S; Li J; Lu J; Zhang Q; Zhang D; Wang R; Zhao Y
    Clin Neurol Neurosurg; 2019 Mar; 178():86-92. PubMed ID: 30763783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of revascularization surgery on cerebral hemodynamics in adult moyamoya disease.
    Onodera K; Ooigawa H; Tabata S; Kimura T; Lepic M; Suzuki K; Kurita H
    Clin Neurol Neurosurg; 2024 Apr; 239():108180. PubMed ID: 38452713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome.
    Kuroda S; Houkin K; Ishikawa T; Nakayama N; Iwasaki Y
    Neurosurgery; 2010 Jun; 66(6):1093-101; discussion 1101. PubMed ID: 20495424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Moyamoya disease: 320-multidetector row CT for evaluation of revascularization in STA-MCA bypasses surgery.
    Tian B; Xu B; Liu Q; Hao Q; Lu J
    Eur J Radiol; 2013 Dec; 82(12):2342-7. PubMed ID: 24094737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial temporal artery-to-middle cerebral artery anastomosis with encephalo-duro-myo-synangiosis as a modified operative procedure for moyamoya disease.
    Ishii K; Morishige M; Anan M; Sugita K; Abe E; Kubo T; Fujiki M; Kobayashi H
    Acta Neurochir Suppl; 2010; 107():95-9. PubMed ID: 19953378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.